Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI-Containing vs PI-Sparing Regimen and IL-2 in Acute/Early HIV Infection
NCT00006154Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aldesleukin, efavirenz, indinavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
aldesleukinefavirenzindinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00006154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006154.